Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Is Lipoprotein-a Just a Lipid Marker or a Predictor for the Severity of Coronary Lesions in Aortic Valve Sclerosis Patients?

NCT07209631 is registered in ClinicalTrials.gov with Sohag University as lead sponsor.

NCT NCT07209631
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07209631 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Is Lipoprotein-a Just a Lipid Marker or a Predictor for the Severity of Coronary Lesions in Aortic Valve Sclerosis Patients?
Lead sponsor
Sohag University
Phase
Observational
Overall status
Completed
Start date
October 1, 2024
Completion date
May 1, 2025
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aortic valve sclerosis, coronary artery disease, lipoprotein(a), serum, severity